344 related articles for article (PubMed ID: 26778414)
1. Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
Chappell G; Silva GO; Uehara T; Pogribny IP; Rusyn I
Cancer Med; 2016 Mar; 5(3):574-85. PubMed ID: 26778414
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.
Chappell G; Kutanzi K; Uehara T; Tryndyak V; Hong HH; Hoenerhoff M; Beland FA; Rusyn I; Pogribny IP
Int J Cancer; 2014 Jun; 134(12):2778-88. PubMed ID: 24242335
[TBL] [Abstract][Full Text] [Related]
3. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
4. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
[TBL] [Abstract][Full Text] [Related]
5. Sex-related differences in DNA copy number alterations in hepatitis B virus-associated hepatocellular carcinoma.
Zhu ZZ; Wang D; Cong WM; Jiang H; Yu Y; Wen BJ; Dong H; Zhang X; Liu SF; Wang AZ; Zhu G; Hou L
Asian Pac J Cancer Prev; 2012; 13(1):225-9. PubMed ID: 22502674
[TBL] [Abstract][Full Text] [Related]
6. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.
Wong N; Lai P; Lee SW; Fan S; Pang E; Liew CT; Sheng Z; Lau JW; Johnson PJ
Am J Pathol; 1999 Jan; 154(1):37-43. PubMed ID: 9916916
[TBL] [Abstract][Full Text] [Related]
7. Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach.
Friemel J; Frick L; Unger K; Egger M; Parrotta R; Böge YT; Adili A; Karin M; Luedde T; Heikenwalder M; Weber A
Mol Cancer Res; 2019 Jul; 17(7):1493-1502. PubMed ID: 30967480
[TBL] [Abstract][Full Text] [Related]
8. Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma.
Bassaganyas L; Pinyol R; Esteban-Fabró R; Torrens L; Torrecilla S; Willoughby CE; Franch-Expósito S; Vila-Casadesús M; Salaverria I; Montal R; Mazzaferro V; Camps J; Sia D; Llovet JM
Clin Cancer Res; 2020 Dec; 26(23):6350-6361. PubMed ID: 32873569
[TBL] [Abstract][Full Text] [Related]
9. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.
Yeh MM; Liu Y; Torbenson M
Hum Pathol; 2015 Nov; 46(11):1769-75. PubMed ID: 26410018
[TBL] [Abstract][Full Text] [Related]
10. Loss at 16q22.1 identified as a risk factor for intrahepatic recurrence in hepatocellular carcinoma and screening of differentially expressed genes.
Chen L; Zhu ZZ; Liu SF; Wan X; Wen BJ; Jiang H; Zhu J; Cong WM
Neoplasma; 2016; 63(1):114-20. PubMed ID: 26639241
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
12. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
[TBL] [Abstract][Full Text] [Related]
13. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
14. Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease.
Zimonjic DB; Ullmannova-Benson V; Factor VM; Thorgeirsson SS; Popescu NC
Cancer Genet Cytogenet; 2009 May; 191(1):17-26. PubMed ID: 19389504
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma.
Guo L; Yi X; Chen L; Zhang T; Guo H; Chen Z; Cheng J; Cao Q; Liu H; Hou C; Qi L; Zhu Z; Liu Y; Kong R; Zhang C; Zhou X; Zhang Z; Song T; Xue R; Zhang N
Gastroenterology; 2022 Jan; 162(1):238-252. PubMed ID: 34481846
[TBL] [Abstract][Full Text] [Related]
16. Gain of UBE2D1 facilitates hepatocellular carcinoma progression and is associated with DNA damage caused by continuous IL-6.
Zhou C; Bi F; Yuan J; Yang F; Sun S
J Exp Clin Cancer Res; 2018 Nov; 37(1):290. PubMed ID: 30482241
[TBL] [Abstract][Full Text] [Related]
17. Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.
Wang D; Zhu ZZ; Jiang H; Zhu J; Cong WM; Wen BJ; He SQ; Liu SF
Hepatol Int; 2015 Jul; 9(3):438-46. PubMed ID: 26067772
[TBL] [Abstract][Full Text] [Related]
18. Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up.
Cho HJ; Kim SS; Wang HJ; Kim BW; Cho H; Jung J; Cho SS; Kim JK; Lee JH; Kim YB; Yang MJ; Yoo BM; Lee KJ; Cho SW; Cheong JY
DNA Cell Biol; 2016 Feb; 35(2):71-80. PubMed ID: 26624274
[TBL] [Abstract][Full Text] [Related]
19. Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype.
Kwon SM; Kim DS; Won NH; Park SJ; Chwae YJ; Kang HC; Lee SH; Baik EJ; Thorgeirsson SS; Woo HG
Carcinogenesis; 2013 Jul; 34(7):1543-50. PubMed ID: 23508637
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
